$1.5 million grant awarded to Utah cancer researcher

$1.5 million grant awarded to Utah cancer researcher

(File Photo)


Save Story
Leer en español

Estimated read time: 1-2 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

SALT LAKE CITY — A Utah researcher is getting big money to study specific genes that play a role in the cause and spreading of melanoma.

Dr. Matt VanBrocklin, a Huntsman Cancer Institute investigator and assistant professor in the University of Utah's Department of Surgery, received a $1.5 million grant from the National Cancer Institute and the NAtional Institutes of Health to continue his research on mutations in c-KIT. It is already identified as the most common cancer-causing event in certain melanomas, including those caused by chronic sun damage.

VanBrocklin is using mice to track the role of c-KIT and test whether active c-KIT can cause melanoma, a devastating and sometimes deadly skin cancer.

"We need to discover more details about how c-KIT works in melanoma tumors and what other genetic factors may be interacting with it as the cancer progresses and spreads to other parts of the body," he said.

The goal of the ongoing research is to develop new, more effective treatments for patients whose tumors have similar gene mutations.

More than 76,600 people have been diagnosed with melanoma in the United States this year, and the disease has killed more than 9,480 people so far, according to the National Institutes of Health.

Related stories

Most recent Utah stories

Related topics

Utah
Wendy Leonard

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast